• SENSEX 76,536.47
    511.96 (+0.67%)
  • BANKNIFTY 50,827.50
    -737.35 (--1.43%)
  • IndusInd Bank
    708.45 1,576.00(%)
  • Dr Lal Pathlabs
    2,494.00 3,645.00(%)
  • ICICI BLR Growth
    1,003.14 1,001.47(%)
  • Vodafone Idea
    8.33 19.15(%)
  • Bharat Electron
    274.50 204.00(%)
  • Kalyan Jewellers
    503.80 794.60(%)
  • Quadrant Future
    605.00 743.45(%)
  • SRF
    2,974.30 3,074.95(%)
  • Zomato Ltd
    210.60 304.50(%)
  • SpiceJet
    46.10 79.90(%)
  • ICICI Bank
    1,338.00 1,372.50(%)
  • Mazagon Dock
    2,601.00 2,929.98(%)
  • Dixon Technolog.
    13,471.75 19,149.80(%)
  • Aegis Logistics
    830.35 1,035.70(%)
  • Adani Green
    944.45 2,173.65(%)
  • Suzlon Energy
    56.95 86.04(%)
  • M & M
    2,627.00 1,891.30(%)
  • Hind.Aeronautics
    4,252.00 5,675.00(%)
  • Tata Motors
    662.00 606.20(%)
  • Nippon ETF Liq.
    999.99 996.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Glenmark Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 20600.0
  • ISIN : INE935A01035
1,509.20 -32 (-2.07%)
  • As on 02 Apr 2025 (EOD)

  • Today’s Low

    1,498.15

  • Today’s High

    1,558.30

  • Open

    1,540.00

  • Perv Close

    1,541.05

  • 52W Low

    959.05

  • 52W High

    1,830.95

Key Indicators

  • P/E(TTM)

    18.48

  • Mar.Cap (₹Cr.)

    42,587.84

  • Div & Yield %

    0.17

  • Book Value(₹)

    848.58

  • Debt-Equity Ratio

    -2.07

  • AGM Date

    01-Apr-2025

  • EPS

    81.65

  • P/E Ratio

    18.48

Financials Ratios

  • Debt-Equity Ratio

    0.34

  • Mar.Cap (₹Cr.)

    42,587.84

  • RONW (%)

    -50.87

  • ROCE (%)

    12.05

Score Board

  • Equity (₹ in Cr.)

    28.22

  • BV (₹)

    848.60

  • Sales( ₹ in Cr.)

    7,891.12

  • NP (in Cr.)

    1,425.03

  • NP Var(%)

    -10.0

  • Div%

    250.0

  • CPS (₹)

    57.70

  • EPS (₹)

    50.50

  • Traded Value (₹ in Lakhs)

    42,575.14

  • 52 Week High

    1,830.95

  • 52 Week Low

    959.05

  • Price BSE

    1509.0

  • Price NSE

    1,509.00

  • Market Capital( in Cr.)

    42,575.14

  • P/C Ratio

    26.20

  • P/E Ratio

    29.90

  • Price Vs.BV

    50.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 7,891.12 8,220.66 8,141.58 7,567.93 6,712.63 6,304.87
Excise Duty 7,627.81 7,998.18 7,991.98 7,424.98 6,413.14 6,072.35
Net Sales 7,891.12 8,220.66 8,141.58 7,567.93 6,712.63 6,304.87
Other Income 1,168.02 985.94 614.63 396.24 606.79 475.61
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 9,059.14 9,206.60 8,756.21 7,964.17 7,319.42 6,780.48
EXPENDITURE :
Raw Materials 7,627.81 7,998.18 7,991.98 7,424.98 6,413.14 6,072.35
Power & Fuel Cost 7,627.81 7,998.18 7,991.98 7,424.98 6,413.14 6,072.35
Employee Cost 1,434.78 1,346.51 1,193.20 1,107.40 1,072.33 969.98
Other Manufacturing Expenses 325.15 359.85 349.97 358.30 371.53 353.89
Selling & Administrative Expenses 1,306.69 1,342.28 1,153.58 991.30 1,060.23 1,063.69
Miscellaneous Expenses 325.15 359.85 349.97 358.30 371.53 353.89
Less : Pre-operative Expenses Capitalised :
Total Expenditure 7,128.73 7,138.86 6,849.10 6,094.31 5,803.33 5,307.48
Operating Profit 372.71 303.56 298.10 270.83 238.33 230.87
Interest 277.11 206.82 236.04 265.90 256.39 223.81
Gross Profit 7,000.75 1,571.87 2,337.45 1,943.76 1,534.64 1,818.18
Depreciation 202.16 184.15 159.70 150.82 138.54 106.28
Profit Before Tax 7,000.75 1,571.87 2,337.45 1,943.76 1,534.64 1,818.18
Tax 1,049.99 386.93 411.08 343.62 269.24 383.50
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 783.46 -23.83 -71.42 -49.31 -89.14 -53.61
Reported Net Profit 5,167.29 1,208.77 1,997.79 1,649.45 1,354.55 1,488.30
Extraordinary Items 7,000.75 1,571.87 2,337.45 1,943.76 1,534.64 1,818.18
Adjusted Net Profit 5,167.29 1,208.77 1,997.79 1,649.45 1,354.55 1,488.30
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 202.83
Statutory Appropriations 70.55 70.54 70.54 70.54 70.54 56.43
P & L Balance carried down 5,167.29 1,208.77 1,997.79 1,649.45 1,354.55 1,488.30
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 250.00 250.00 250.00 250.00 250.00 200.00
Dividend Per Share(Rs) 2.50 2.50 2.50 2.50 2.50 2.00
Earnings Per Share-Unit Curr 183.13 42.84 70.80 58.46 48.00 57.49
Book Value 70.55 70.54 70.54 70.54 70.54 56.43
Book Value(Adj)-Unit Curr 70.55 70.54 70.54 70.54 70.54 56.43

Shareholding Pattern

  • Promoter Group

    46.65%

  • Public Share Holding

    53.35%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,389,251 1.20 3,389,251 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 128,241,936 45.45 128,241,936 1
Others 0 0.00 0 0
Sub Total 131,631,187 46.65 131,631,187 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 107,037 0.04 107,037 3
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,740 0.00 1,740 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 66,336,736 23.51 66,336,736 348
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,320,111 0.47 1,320,111 12
Mutual Funds / UTI 34,189,597 12.12 34,189,597 25
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 3,568,731 1.26 3,568,731 12
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 105,523,952 37.39 105,523,952 402
2] Non Institution
Bodies Corporate 6,330,194 2.24 6,330,194 813
Clearing Members 26,252 0.01 26,252 9
Directors of their Relatives 600 0.00 600 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,099,154 0.74 2,095,154 4,509
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 539,610 0.19 539,610 3,298
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 13,369,696 4.74 12,769,696 16
Individuals holding nominal share capital up to Rs. 1 lakh 22,317,534 7.91 22,077,200 185,992
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 59,307 0.02 59,307 10
Others 290,670 0.10 290,670 3
Sub Total 45,033,017 15.96 44,188,683 194,651
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 282,188,156 100.00 281,343,822 195,059

Company Background

Glenmark Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Glenmark Pharmaceuticals Ltd
  • BSE Code : 20600.0
  • ISIN : INE935A01035

  • Incorporation Year

    1977

  • Registered Office

    B/2 Mahalaxmi Chambers
    22 Bhulabhai Desai Road, Mumbai,
    Maharashtra-400026

  • Telephone

    91-22-40189999

  • FAX

    91-22-40189986

  • Chairman

    Glenn Saldanha

  • Managing Director

    Glenn Saldanha

  • Company Secretary

  • Auditor

    Suresh Surana & Associates LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Glenmark Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Glenmark Pharma. 1,508.75 9,059.14 7,891.12 7.01 9.75
Abbott India 30,305.85 6,097.18 5,848.91 48.26 44.71
Astrazeneca Phar 8,518.55 1,330.33 1,295.53 219.61 33.26
P & G Health Ltd 5,152.30 1,166.89 1,151.26 36.15 39.76
Glaxosmi. Pharma 2,793.40 3,530.73 3,407.25 55.55 44.44
Cipla 1,444.55 17,645.00 16,574.34 24.77 20.10
Amrutanjan Healt 642.85 437.58 421.23 37.68 20.84
Fermenta Biotec. 285.30 315.24 307.09 27.04 4.10
Guj. Themis Bio. 271.85 174.19 169.82 56.28 44.82
Bliss GVS Pharma 119.25 638.96 605.46 27.29 11.19
Ambalal Sarabhai 36.15 11.70 3.81 15.45 1.92